Could the Urease of the Gut Bacterium Proteus mirabilis Play a Role in the Altered Gut–Brain Talk Associated with Parkinson’s Disease?
暂无分享,去创建一个
C. Carlini | C. Follmer | A. Perin | G. Neves | M. Grahl | B. Andrade | A. F. Uberti | Laura de Souza Duarte | Kelvin Siqueira Hohl
[1] C. Carlini,et al. One enzyme, many faces: urease is also canatoxin. , 2022, Journal of biomolecular structure & dynamics.
[2] Samy I McFarlane,et al. Hyperammonemic Encephalopathy Secondary to Urinary Tract Infection , 2022, Cureus.
[3] A. Sitta,et al. Clinical findings of patients with hyperammonemia affected by urea cycle disorders with hepatic encephalopathy , 2022, International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience.
[4] A. Lang,et al. The microbiome–gut–brain axis in Parkinson disease — from basic research to the clinic , 2022, Nature Reviews Neurology.
[5] L. Wold,et al. Influence of the Microbiota-Gut-Brain Axis on Cognition in Alzheimer's Disease. , 2022, Journal of Alzheimer's disease : JAD.
[6] Mei Sun,et al. Brain-gut-microbiota axis in Parkinson’s disease: A historical review and future perspective , 2022, Brain Research Bulletin.
[7] C. Carlini,et al. Helicobacter pylori Urease: Potential Contributions to Alzheimer’s Disease , 2022, International journal of molecular sciences.
[8] Lianmei Zhao,et al. Outer Membrane Vesicles Secreted by Helicobacter pylori Transmitting Gastric Pathogenic Virulence Factors , 2021, ACS omega.
[9] Tingtao Chen,et al. Neuroprotective Effect of Ceftriaxone on MPTP-Induced Parkinson's Disease Mouse Model by Regulating Inflammation and Intestinal Microbiota , 2021, Oxidative medicine and cellular longevity.
[10] F. C. Lopes,et al. Non-enzymatic properties of Proteus mirabilis urease subunits , 2021 .
[11] C. Carlini,et al. Proteus mirabilis Urease: Unsuspected Non-Enzymatic Properties Relevant to Pathogenicity , 2021, International journal of molecular sciences.
[12] Yung-ching Liu,et al. Proteus mirabilis thoracic vertebral osteomyelitis: a case report , 2021, Journal of Medical Case Reports.
[13] Nam Ki Lee,et al. Cooperative inhibition of SNARE-mediated vesicle fusion by α-synuclein monomers and oligomers , 2021, Scientific Reports.
[14] S. Schild,et al. Outer Membrane Vesicles of Vibrio cholerae Protect and Deliver Active Cholera Toxin to Host Cells via Porin-Dependent Uptake , 2021, mBio.
[15] Serene W. Chen,et al. Exploring the Release of Toxic Oligomers from α-Synuclein Fibrils with Antibodies and STED Microscopy , 2021, Life.
[16] C. Guerri,et al. Role of Microbiota-Derived Extracellular Vesicles in Gut-Brain Communication , 2021, International journal of molecular sciences.
[17] S. Reich-Zeliger,et al. P-selectin axis plays a key role in microglia immunophenotype and glioblastoma progression , 2021, Nature Communications.
[18] M. Mendez. The Relationship Between Anxiety and Alzheimer’s Disease , 2021, Journal of Alzheimer's disease reports.
[19] J. Tytgat,et al. Neurotoxic and convulsant effects induced by Jack Bean Ureases on the Mammalian Nervous System. , 2021, Toxicology.
[20] Rui Zhong,et al. Helicobacter pylori infection is associated with a poor response to levodopa in patients with Parkinson’s disease: a systematic review and meta-analysis , 2021, Journal of Neurology.
[21] C. Williams-Gray,et al. Neuroinflammation and protein pathology in Parkinson’s disease dementia , 2020, Acta neuropathologica communications.
[22] Feng Xiao,et al. Nootkatone improves anxiety‐ and depression‐like behavior by targeting hyperammonemia‐induced oxidative stress in D‐galactosamine model of liver injury , 2020, Environmental toxicology.
[23] K. Earasi,et al. Proteus empyema as a rare complication from an infected renal cyst, a case report , 2020, BMC Pulmonary Medicine.
[24] S. Rates,et al. Intermittent repeated stress but not ketamine changes mice response to antidepressants , 2020, Neuroscience Letters.
[25] C. Follmer,et al. In Vitro Protective Action of Monomeric and Fibrillar α-Synuclein on Neuronal Cells Exposed to the Dopaminergic Toxins Salsolinol and DOPAL. , 2020, ACS chemical neuroscience.
[26] Asad F. Durrani,et al. Proteus mirabilis Keratitis: Risk Factors, Clinical Features, Treatment Outcomes, and Microbiological Characteristics. , 2020, Cornea.
[27] Ajmal Ahmad,et al. The Role of Neurovascular System in Neurodegenerative Diseases , 2020, Molecular Neurobiology.
[28] W. Banks,et al. Transport of Extracellular Vesicles across the Blood-Brain Barrier: Brain Pharmacokinetics and Effects of Inflammation , 2020, International journal of molecular sciences.
[29] J. Trojanowski,et al. Protein transmission in neurodegenerative disease , 2020, Nature Reviews Neurology.
[30] J. Massano,et al. [Parkinson's Disease: Clinical Review and Update]. , 2019, Acta medica portuguesa.
[31] Nathalie Van Den Berge,et al. Evidence for bidirectional and trans-synaptic parasympathetic and sympathetic propagation of alpha-synuclein in rats , 2019, Acta Neuropathologica.
[32] M. Diamond,et al. Propagation of Protein Aggregation in Neurodegenerative Diseases. , 2019, Annual review of biochemistry.
[33] C. Carlini,et al. Helicobacter pylori urease induces pro‐inflammatory effects and differentiation of human endothelial cells: Cellular and molecular mechanism , 2019, Helicobacter.
[34] A. Lobo,et al. Clinically relevant anxiety and risk of Alzheimer's disease in an elderly community sample: 4.5 years of follow-up. , 2019, Journal of affective disorders.
[35] Yeong Shik Kim,et al. Matrine ameliorates anxiety and depression-like behaviour by targeting hyperammonemia-induced neuroinflammation and oxidative stress in CCl4 model of liver injury. , 2019, Neurotoxicology.
[36] R. Sakakibara,et al. Lewy body constipation , 2019, Journal of the anus, rectum and colon.
[37] K. Kristensson,et al. Circumventricular Organs and Parasite Neurotropism: Neglected Gates to the Brain? , 2018, Front. Immunol..
[38] N. Cairns,et al. Parkinson's disease and multiple system atrophy have distinct α-synuclein seed characteristics , 2018, The Journal of Biological Chemistry.
[39] Honglei Chen,et al. The vermiform appendix impacts the risk of developing Parkinson’s disease , 2018, Science Translational Medicine.
[40] E. Disbrow,et al. Stomaching the Possibility of a Pathogenic Role for Helicobacter pylori in Parkinson’s Disease , 2018, Journal of Parkinson's disease.
[41] Daniel J. L. L. Pinheiro,et al. Acute and chronic neurological consequences of early-life Zika virus infection in mice , 2018, Science Translational Medicine.
[42] M. Giron,et al. Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson’s Disease , 2018, International journal of molecular sciences.
[43] C. Carlini,et al. Ureases: Historical aspects, catalytic, and non-catalytic properties – A review , 2018, Journal of advanced research.
[44] R. Takahashi,et al. Inoculation of α-synuclein preformed fibrils into the mouse gastrointestinal tract induces Lewy body-like aggregates in the brainstem via the vagus nerve , 2018, Molecular Neurodegeneration.
[45] John L. Robinson,et al. Cellular Milieu Imparts Distinct Pathological α-Synuclein Strains in α-Synucleinopathies , 2018, Nature.
[46] I. Horváth,et al. Abundant fish protein inhibits α-synuclein amyloid formation , 2018, Scientific Reports.
[47] H. Mobley,et al. Pathogenesis of Proteus mirabilis Infection. , 2018, EcoSal Plus.
[48] M. Doulberis,et al. Review: Impact of Helicobacter pylori on Alzheimer's disease: What do we know so far? , 2018, Helicobacter.
[49] M. Oh,et al. Oral administration of Proteus mirabilis damages dopaminergic neurons and motor functions in mice , 2018, Scientific Reports.
[50] C. Carlini,et al. The Impact of Helicobacter pylori Urease upon Platelets and Consequent Contributions to Inflammation , 2017, Front. Microbiol..
[51] G. Frisoni,et al. Microbiota and neurodegenerative diseases , 2017, Current opinion in neurology.
[52] E. Quigley. Microbiota-Brain-Gut Axis and Neurodegenerative Diseases , 2017, Current Neurology and Neuroscience Reports.
[53] A. Björklund,et al. Modeling Parkinson’s disease pathology by combination of fibril seeds and α-synuclein overexpression in the rat brain , 2017, Proceedings of the National Academy of Sciences.
[54] E. Pekkonen,et al. More than constipation – bowel symptoms in Parkinson's disease and their connection to gut microbiota , 2017, European journal of neurology.
[55] A. Axon,et al. Epidemiology of Helicobacter pylori infection , 2017, Helicobacter.
[56] A. Heintz‐Buschart,et al. The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorder , 2017, Movement disorders : official journal of the Movement Disorder Society.
[57] P. Svenningsson,et al. Vagotomy and Parkinson disease , 2017, Neurology.
[58] Wei Li,et al. Structural changes of gut microbiota in Parkinson’s disease and its correlation with clinical features , 2017, Science China Life Sciences.
[59] Dennis W Dickson,et al. Pathology of Neurodegenerative Diseases. , 2017, Cold Spring Harbor perspectives in biology.
[60] Rob Knight,et al. Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease , 2016, Cell.
[61] N. Inestrosa,et al. Amyloid-β Peptide Nitrotyrosination Stabilizes Oligomers and Enhances NMDAR-Mediated Toxicity , 2016, The Journal of Neuroscience.
[62] F. C. Lopes,et al. Interaction of jack bean (Canavalia ensiformis) urease and a derived peptide with lipid vesicles. , 2016, Colloids and surfaces. B, Biointerfaces.
[63] B. Albensi,et al. Ammonia as a Potential Neurotoxic Factor in Alzheimer's Disease , 2016, Front. Mol. Neurosci..
[64] S. Winder,et al. A Modified Wire Hanging Apparatus for Small Animal Muscle Function Testing , 2016, PLoS currents.
[65] Igor L. Medintz,et al. Protecting enzymatic function through directed packaging into bacterial outer membrane vesicles , 2016, Scientific Reports.
[66] C. Carlini,et al. Ureases as multifunctional toxic proteins: A review. , 2016, Toxicon : official journal of the International Society on Toxinology.
[67] Dominika Drzewiecka. Significance and Roles of Proteus spp. Bacteria in Natural Environments , 2016, Microbial Ecology.
[68] M. Suciu,et al. Heterogeneity of the blood-brain barrier , 2016, Tissue barriers.
[69] H. Reichmann,et al. Pathogenesis of Parkinson disease—the gut–brain axis and environmental factors , 2015, Nature Reviews Neurology.
[70] N. Saunders,et al. Markers for blood-brain barrier integrity: how appropriate is Evans blue in the twenty-first century and what are the alternatives? , 2015, Front. Neurosci..
[71] J. Fox,et al. Tight junction disruption: Helicobacter pylori and dysregulation of the gastric mucosal barrier. , 2015, World journal of gastroenterology.
[72] E. Horváth-Puhó,et al. Vagotomy and subsequent risk of Parkinson's disease , 2015, Annals of neurology.
[73] Chenghua Gu,et al. The Molecular Constituents of the Blood–Brain Barrier , 2015, Trends in Neurosciences.
[74] Jessica N Schaffer,et al. Proteus mirabilis and Urinary Tract Infections , 2015, Microbiology spectrum.
[75] A. Lang,et al. Parkinson's disease , 2015, The Lancet.
[76] Ali Keshavarzian,et al. Colonic bacterial composition in Parkinson's disease , 2015, Movement disorders : official journal of the Movement Disorder Society.
[77] R. Wu,et al. Risk of Parkinson's disease following anxiety disorders: a nationwide population‐based cohort study , 2015, European journal of neurology.
[78] D. Geschwind,et al. Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonism , 2015, Proceedings of the National Academy of Sciences.
[79] T. Südhof,et al. Propagation of prions causing synucleinopathies in cultured cells , 2015, Proceedings of the National Academy of Sciences.
[80] Bing Ruan,et al. Altered fecal microbiota composition in patients with major depressive disorder , 2015, Brain, Behavior, and Immunity.
[81] M. Giugliano,et al. α-Synuclein strains cause distinct synucleinopathies after local and systemic administration , 2015, Nature.
[82] I. Amit,et al. Host microbiota constantly control maturation and function of microglia in the CNS , 2015, Nature Neuroscience.
[83] A. Lang,et al. Helicobacter pylori infection is associated with worse severity of Parkinson's disease. , 2015, Parkinsonism & related disorders.
[84] E. Pekkonen,et al. Gut microbiota are related to Parkinson's disease and clinical phenotype , 2015, Movement disorders : official journal of the Movement Disorder Society.
[85] J. Trojanowski,et al. Spreading of pathology in neurodegenerative diseases: a focus on human studies , 2015, Nature Reviews Neuroscience.
[86] T. Dinan,et al. Serotonin, tryptophan metabolism and the brain-gut-microbiome axis , 2015, Behavioural Brain Research.
[87] R. Osta,et al. Comparative study of behavioural tests in the SOD1G93A mouse model of amyotrophic lateral sclerosis , 2014, Experimental animals.
[88] C. Maldonado-Bernal,et al. Helicobacter pylori and neurological diseases: Married by the laws of inflammation. , 2014, World journal of gastrointestinal pathophysiology.
[89] Yang Yang,et al. Helicobacter pylori filtrate induces Alzheimer-like tau hyperphosphorylation by activating glycogen synthase kinase-3β. , 2014, Journal of Alzheimer's disease : JAD.
[90] Jia-Yi Li,et al. Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats , 2014, Acta Neuropathologica.
[91] David Padua,et al. Altered brain‐gut axis in autism: Comorbidity or causative mechanisms? , 2014, BioEssays : news and reviews in molecular, cellular and developmental biology.
[92] Yu-Jian Liu,et al. Helicobacter pylori filtrate impairs spatial learning and memory in rats and increases β-amyloid by enhancing expression of presenilin-2 , 2014, Alzheimer's & Dementia.
[93] J. Schwartz,et al. Canavalia ensiformis urease, Jaburetox and derived peptides form ion channels in planar lipid bilayers. , 2014, Archives of biochemistry and biophysics.
[94] A. Yang,et al. Risk of Parkinson disease after depression , 2013, Neurology.
[95] Lin-Feng Chen,et al. Helicobacter pylori activates NF‐κB by inducing Ubc13‐mediated ubiquitination of lysine 158 of TAK1 , 2013, Journal of cellular biochemistry.
[96] C. Follmer,et al. α‐Synuclein as an intrinsically disordered monomer – fact or artefact? , 2013, The FEBS journal.
[97] Mathias Jucker,et al. Self-propagation of pathogenic protein aggregates in neurodegenerative diseases , 2013, Nature.
[98] Lola Fenghuei Yen,et al. Distinct Patterns of Cerebral Extravasation by Evans Blue and Sodium Fluorescein in Rats , 2013, PloS one.
[99] C. Carlini,et al. Pro-inflammatory properties and neutrophil activation by Helicobacter pylori urease. , 2013, Toxicon : official journal of the International Society on Toxinology.
[100] J. Foster,et al. Gut–brain axis: how the microbiome influences anxiety and depression , 2013, Trends in Neurosciences.
[101] J. Kountouras,et al. Helicobacter pylori infection and Parkinson’s disease: apoptosis as an underlying common contributor , 2012, European journal of neurology.
[102] M. Aschner,et al. Ammonia increases paracellular permeability of rat brain endothelial cells by a mechanism encompassing oxidative/nitrosative stress and activation of matrix metalloproteinases , 2012, Journal of neurochemistry.
[103] D. Lehman,et al. Cerebral Abscess Complicating Proteus mirabilis Meningitis in a Newborn Infant , 2012, Journal of child neurology.
[104] Adem Can,et al. The tail suspension test. , 2011, Journal of visualized experiments : JoVE.
[105] C. Carlini,et al. Characterization of JBURE-IIb isoform of Canavalia ensiformis (L.) DC urease. , 2011, Biochimica et biophysica acta.
[106] R. Peek,et al. "Targeted disruption of the epithelial-barrier by Helicobacter pylori" , 2011, Cell Communication and Signaling.
[107] David S. Miller,et al. Neuropsychiatric symptoms in Alzheimer’s disease , 2011, Alzheimer's & Dementia.
[108] Mark E. Shirtliff,et al. Proteus mirabilis biofilms and catheter-associated urinary tract infections , 2011, Virulence.
[109] M. Skowrońska,et al. Alterations of Blood Brain Barrier Function in Hyperammonemia: An Overview , 2011, Neurotoxicity Research.
[110] Thomas G Beach,et al. Neuropathological findings of PSP in the elderly without clinical PSP: possible incidental PSP? , 2011, Parkinsonism & related disorders.
[111] D. Maraganore,et al. Incidental Lewy body disease: Do some cases represent a preclinical stage of dementia with Lewy bodies? , 2011, Neurobiology of Aging.
[112] K. Rankin,et al. The diagnostic challenge of psychiatric symptoms in neurodegenerative disease: rates of and risk factors for prior psychiatric diagnosis in patients with early neurodegenerative disease. , 2011, The Journal of clinical psychiatry.
[113] John H. Zhang,et al. Comparison Evans Blue injection routes: Intravenous versus intraperitoneal, for measurement of blood–brain barrier in a mice hemorrhage model , 2011, Journal of Neuroscience Methods.
[114] Katja Petzold,et al. Biochemical and functional characterization of Helicobacter pylori vesicles , 2010, Molecular microbiology.
[115] Xuemei Huang,et al. Depression and the subsequent risk of Parkinson's disease in the NIH‐AARP Diet and Health Study , 2010, Movement disorders : official journal of the Movement Disorder Society.
[116] C. Carlini,et al. Helicobacter pylori urease activates blood platelets through a lipoxygenase-mediated pathway , 2010, Journal of cellular and molecular medicine.
[117] H. Shill,et al. Incidental Lewy body disease: Clinical comparison to a control cohort , 2010, Movement disorders : official journal of the Movement Disorder Society.
[118] E. Barreiro,et al. Searching for multi-target antipsychotics: Discovery of orally active heterocyclic N-phenylpiperazine ligands of D2-like and 5-HT1A receptors. , 2010, Bioorganic & medicinal chemistry.
[119] R. Khalil,et al. Inflammatory cytokines in vascular dysfunction and vascular disease. , 2009, Biochemical pharmacology.
[120] M. Sierks,et al. Intracellular targeting and clearance of oligomeric alpha-synuclein alleviates toxicity in mammalian cells , 2009, Neuroscience Letters.
[121] B. Krajewska. Ureases I. Functional, catalytic and kinetic properties: A review , 2009 .
[122] J. A. Guimarães,et al. Central nervous effects of the convulsant protein canatoxin. , 2009, Acta pharmacologica et toxicologica.
[123] C. Rose,et al. Identifying the direct effects of ammonia on the brain , 2009, Metabolic Brain Disease.
[124] M. Tsolaki,et al. Increased Cerebrospinal Fluid Helicobacter Pylori Antibody in Alzheimer’s Disease , 2009, The International journal of neuroscience.
[125] G. Pasquali,et al. Antifungal activity of plant and bacterial ureases. , 2007, Toxicon : official journal of the International Society on Toxinology.
[126] D. Rigden,et al. Jaburetox-2Ec: An insecticidal peptide derived from an isoform of urease from the plant Canavalia ensiformis , 2007, Peptides.
[127] M. Tsolaki,et al. Association between Helicobacter pylori infection and mild cognitive impairment , 2007, European journal of neurology.
[128] H. Poppel,et al. Urea-splitting urinary tract infection contributing to hyperammonemic encephalopathy , 2007, Nature Clinical Practice Urology.
[129] A M Stiggelbout,et al. Patient-reported autonomic symptoms in Parkinson disease , 2007, Neurology.
[130] M. Horne,et al. Plasma α-synuclein is decreased in subjects with Parkinson's disease , 2007, Experimental Neurology.
[131] S. Stanford. The Open Field Test: reinventing the wheel , 2007, Journal of psychopharmacology.
[132] T. Tokuda,et al. Decreased α-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson’s disease. , 2006 .
[133] C. Carlini,et al. Bacillus pasteurii urease shares with plant ureases the ability to induce aggregation of blood platelets. , 2006, Archives of biochemistry and biophysics.
[134] M. Tsolaki,et al. Relationship between Helicobacter pylori infection and Alzheimer disease , 2006, Neurology.
[135] H. Braak,et al. Gastric α-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology , 2006, Neuroscience Letters.
[136] J. Seo,et al. Helicobacter pylori Urease Induces Mouse Death , 2005 .
[137] Hansjürgen Bratzke,et al. Stages in the development of Parkinson’s disease-related pathology , 2004, Cell and Tissue Research.
[138] M. Hascöet,et al. The mouse light/dark box test. , 2003, European journal of pharmacology.
[139] A. Torres,et al. Helicobacter pylori: ¿un nuevo factor de riesgo cardiovascular? , 2002 .
[140] C. Carlini,et al. Canatoxin, a toxic protein from jack beans (Canavalia ensiformis), is a variant form of urease (EC 3.5.1.5): biological effects of urease independent of its ureolytic activity. , 2001, The Biochemical journal.
[141] H. Becher,et al. Helicobacter pylori infection as an independent risk factor for cerebral ischemia of atherothrombotic origin , 2001, Journal of the Neurological Sciences.
[142] R. Polin,et al. Neonatal bacterial meningitis. , 2001, Seminars in neonatology : SN.
[143] D. Zochodne,et al. Reversible parkinsonism and hyperammonemia associated with portal vein thrombosis , 2001, Acta neurologica Scandinavica.
[144] C. Carlini,et al. Proteolytic activation of canatoxin, a plant toxic protein, by insect cathepsin-like enzymes. , 2000, Archives of insect biochemistry and physiology.
[145] B. Trapp,et al. Detection of MHC class II-antigens on macrophages and microglia, but not on astrocytes and endothelia in active multiple sclerosis lesions , 1994, Journal of Neuroimmunology.
[146] G. Ribeiro-DaSilva,et al. Increased insulin circulating levels induced by canatoxin in rats. , 1993, Toxicon : official journal of the International Society on Toxinology.
[147] D. Dickson,et al. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease , 1993, Glia.
[148] C. Barja-Fidalgo,et al. Pharmacological characterization of rat paw edema induced by canatoxin, the toxic protein from Canavalia ensiformis (jack bean) seeds. , 1992, Toxicon : official journal of the International Society on Toxinology.
[149] F. Cunha,et al. Role of resident macrophages in canatoxin-induced in vivo neutrophil migration , 1992, Inflammation.
[150] P. Mcgeer,et al. Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains , 1988, Neurology.
[151] H. Mobley,et al. Proteus mirabilis urease: genetic organization, regulation, and expression of structural genes , 1988, Journal of bacteriology.
[152] W. Gibb,et al. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. , 1988, Journal of neurology, neurosurgery, and psychiatry.
[153] N. Ogawa,et al. A simple quantitative bradykinesia test in MPTP-treated mice. , 1985, Research communications in chemical pathology and pharmacology.
[154] J. A. Guimarães,et al. Platelet release reaction and aggregation induced by canatoxin, a convulsant protein: evidence for the involvement of the platelet lipoxygenase pathway , 1985, British journal of pharmacology.
[155] M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.
[156] V H Denenberg,et al. OPEN‐FIELD BEHAVIOR IN THE RAT: WHAT DOES IT MEAN? * , 1969, Annals of the New York Academy of Sciences.
[157] L. D. Snorf,et al. Pneumonia due to Proteus mirabilis treated with penicillin and streptomycin. , 1947, Journal of the American Medical Association.
[158] W. Reith. Neurodegenerative Erkrankungen , 2018, Der Radiologe.
[159] Y. Hayashi,et al. [A case of hyperammonemia resulting from urinary tract infection caused by urease-producing bacteria in a Parkinson's disease patient with drug-induced urinary retention]. , 2017, Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics.
[160] J. Volkmann,et al. Parkinson disease , 2017, Nature Reviews Disease Primers.
[161] .. M. O’Mahonya,et al. eview erotonin , tryptophan metabolism and the brain-gut-microbiome axis , 2014 .
[162] Alok Gupta,et al. Role of Helicobacter pylori infection in the pathogenesis of minimal hepatic encephalopathy and effect of its eradication , 2011 .
[163] M. Figueiredo-Pereira,et al. Relationship between tau pathology and neuroinflammation in Alzheimer's disease. , 2010, The Mount Sinai journal of medicine, New York.
[164] R. Peek,et al. Helicobacter pylori dysregulation of gastric epithelial tight junctions by urease-mediated myosin II activation. , 2009, Gastroenterology.
[165] R. Lister. The use of a plus-maze to measure anxiety in the mouse , 2004, Psychopharmacology.
[166] B. Thierry,et al. The tail suspension test: A new method for screening antidepressants in mice , 2004, Psychopharmacology.
[167] K. Wakabayashi,et al. Symposium II: Idiopathic parkinsonism: From pathohistology to molecular pathology Neurotoxicity of MPTP , 2001 .
[168] J. A. Guimarães,et al. Lipoxygenase-mediated secretory effect of canatoxin the toxic protein from Canavalia ensiformis seeds. , 1991, Toxicon : official journal of the International Society on Toxinology.
[169] J. A. Guimarães,et al. Blood glucose alterations induced in rats by canatoxin, a protein isolated from jack bean (Canavalia ensiformis) seeds. , 1986, Toxicon : official journal of the International Society on Toxinology.